These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10297946)

  • 41. Controlling pharmacy costs in the NC Medicaid program.
    Dobson LA
    N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617
    [No Abstract]   [Full Text] [Related]  

  • 42. Selective risk-sharing: a new reimbursement alternative.
    Leighton R
    Perspect Medicaid Medicare Manage; 1979 Sep; ():15-25. PubMed ID: 10297792
    [No Abstract]   [Full Text] [Related]  

  • 43. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimating pharmacy level prescription drug acquisition costs for third-party reimbursement.
    Kreling DH; Kirk KW
    Med Care; 1986 Jul; 24(7):590-600. PubMed ID: 3523065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M
    Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The elimination of selected drug products from the Michigan Medicaid formulary: a case study.
    Smith DM; McKercher PL
    Hosp Formul; 1984 May; 19(5):366-72. PubMed ID: 10299510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variables affecting pharmacists' willingness to accept third-party prescription contracts: a conjoint analysis.
    Szeinbach SL; Mason HL; Schondelmeyer SN; Collins PD
    J Health Care Mark; 1990 Sep; 10(3):45-50. PubMed ID: 10107469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Capitation reimbursement: a progress report.
    Mangion RM
    Hosp Health Serv Adm; 1986; 31(1):99-110. PubMed ID: 10275080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The potential for administrative cost savings under a capitation reimbursement system for prescription drugs.
    Standridge CR; Capettini R; Myers GM; Rao NB
    Public Health; 1983 Jan; 97(1):46-58. PubMed ID: 6342020
    [No Abstract]   [Full Text] [Related]  

  • 50. Iowa community pharmacies' experiences with Medicaid managed care.
    Urmie JM; Murry LT; Deng H; Doucette WR
    J Am Pharm Assoc (2003); 2020; 60(4):624-630. PubMed ID: 31901442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence and response to the impact of the Medicaid Drug Rebate Program (OBRA) on hospital pharmacy: a progress report from central Ohio.
    Taylor S; Kucukarslan S; Sherrin T
    Hosp Pharm; 1991 Jul; 26(7):621, 624-5. PubMed ID: 10111796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New York State Medicaid dental capitation plan.
    Almog DM
    N Y State Dent J; 1999; 65(7):22-4. PubMed ID: 10500405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incentives in the Medicare prescription drug benefit.
    Natl Bur Econ Res Bull Aging Health; 2006; (15):1-2. PubMed ID: 16805056
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of capitation payment for pharmacy services on pharmacist-dispensing and physician-prescribing behavior: I. Prescription quantity and dose analysis.
    Helling DK; Yesalis CE; Norwood GJ; Burmeister LF; Lipson DP; Fisher WP; Jones ME
    Drug Intell Clin Pharm; 1981; 15(7-8):581-9. PubMed ID: 7018872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medicaid reimbursement.
    Berry MD
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-31. PubMed ID: 18345577
    [No Abstract]   [Full Text] [Related]  

  • 57. Competitive incentive program. Analysis and proposal.
    Stone J
    Am Pharm; 1986 Jul; NS26(7):45-9. PubMed ID: 3529904
    [No Abstract]   [Full Text] [Related]  

  • 58. Medicaid reimbursement. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-13. PubMed ID: 19297676
    [No Abstract]   [Full Text] [Related]  

  • 59. Medicaid and indigent care issue brief: Medicaid: provider reimbursement: year end report-2003.
    Johnson P
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-25. PubMed ID: 14969256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substitution in a Medicaid mental health carve-out: services and costs.
    Libby AM; Cuellar A; Snowden LR; Orton HD
    J Health Care Finance; 2002; 28(4):11-23. PubMed ID: 12148661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.